Neuroprotective potential of the Bahadori leanness program: A "mini-fast with exercise" strategy

Medical Hypotheses

Volumn 68, Issue 5, 2007, Pages 935-940

  McCarty, Mark F ^a   Falahati Nini, Alireza ^b  

^a Natural Alternatives International   (United States)

^b St Mark's Hospital Salt Lake City   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTROPHIC FACTOR; SOMATOMEDIN C;

AEROBIC EXERCISE; APOPTOSIS; ARTICLE; BAHADORI LEANNESS PROGRAM; BODY COMPOSITION; BODY FAT; CEREBROSPINAL FLUID LEVEL; EVALUATION; EXERCISE; GLYCEMIC INDEX; HEALTH PROGRAM; HYPERTENSION; INSULIN SENSITIVITY; METABOLIC STRESS; NEUROCHEMISTRY; NEUROPROTECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK ASSESSMENT; SUDDEN DEATH; SYMPATHETIC TONE;

BLOOD GLUCOSE; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; EXERCISE; FASTING; HUMANS; INSULIN; MODELS, THEORETICAL; THINNESS; TIME FACTORS;

RODENTIA;

EID: 33847243315     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.04.080     Document Type: Article

References (59)

1. Bahadori B. OptiRed: Die 7 Stufen zu Ihrem Gleichgewicht., 2. Auflage ed. 2004.
2. McCarty M.F. Optimizing exercise for fat loss. Med Hypotheses 44 (1995) 325-330
3. Flatt J.P. Dietary fat, carbohydrate balance, and weight maintenance: effects of exercise. Am J Clin Nutr 45 (1987) 296-306
4. Koeslag J.H. Post-exercise ketosis and the hormone response to exercise: a review. Med Sci Sports Exerc 14 (1982) 327-334
5. Bruce-Keller A.J., Umberger G., McFall R., and Mattson M.P. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann Neurol 45 (1999) 8-15
6. Duan W., Guo Z., and Mattson M.P. Brain-derived neurotrophic factor mediates an excitoprotective effect of dietary restriction in mice. J Neurochem 76 (2001) 619-626
7. Mattson M.P., Duan W., and Guo Z. Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J Neurochem 84 (2003) 417-431
8. Anson R.M., Guo Z., de Cabo R., Iyun T., Rios M., Hagepanos A., et al. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc Natl Acad Sci USA 100 (2003) 6216-6220
9. Wan R., Camandola S., and Mattson M.P. Intermittent fasting and dietary supplementation with 2-deoxy-d-glucose improve functional and metabolic cardiovascular risk factors in rats. FASEB J 17 (2003) 1133-1134
10. Ingram D.K., Anson R.M., de Cabo R., Mamczarz J., Zhu M., Mattison J., et al. Development of calorie restriction mimetics as a prolongevity strategy. Ann NY Acad Sci 1019 (2004) 412-423
11. Lee J., Duan W., and Mattson M.P. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 82 (2002) 1367-1375
12. Mattson M.P., Duan W., Wan R., and Guo Z. Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations. Neurorx 1 (2004) 111-116
13. Heilbronn L.K., Smith S.R., Martin C.K., Anton S.D., and Ravussin E. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr 81 (2005) 69-73
14. Korhonen L., Riikonen R., Nawa H., and Lindholm D. Brain derived neurotrophic factor is increased in cerebrospinal fluid of children suffering from asphyxia. Neurosci Lett 240 (1998) 151-154
15. Mattson M.P. Neuroprotective signaling and the aging brain: take away my food and let me run. Brain Res. 886 (2000) 47-53
16. Boden-Albala B., and Sacco R.L. Lifestyle factors and stroke risk: exercise, alcohol, diet, obesity, smoking, drug use, and stress. Curr Atheroscler Rep 2 (2000) 160-166
17. Hanon O., Seux M.L., Lenoir H., Rigaud A.S., and Forette F. Hypertension and dementia. Curr Cardiol Rep 5 (2003) 435-440
18. Skoog I., and Gustafson D. Hypertension, hypertension-clustering factors and Alzheimer's disease. Neurol Res 25 (2003) 675-680
19. Pope S.K., Shue V.M., and Beck C. Will a healthy lifestyle help prevent Alzheimer's disease?. Annu Rev Public Health 24 (2003) 111-132
20. Kiraly M.A., and Kiraly S.J. The effect of exercise on hippocampal integrity: review of recent research. Int J Psychiat Med 35 (2005) 75-89
21. Gustafson D., Rothenberg E., Blennow K., Steen B., and Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Int Med 163 (2003) 1524-1528
22. Luchsinger J.A., and Mayeux R. Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep 6 (2004) 261-266
23. Luchsinger J.A., Tang M.X., Stern Y., Shea S., and Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154 (2001) 635-641
24. Luchsinger J.A., Tang M.X., Shea S., and Mayeux R. Caloric intake and the risk of Alzheimer disease. Arch Neurol 59 (2002) 1258-1263
25. Luchsinger J.A., Tang M.X., Shea S., and Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology 63 (2004) 1187-1192
26. Chen H., Zhang S.M., Schwarzschild M.A., Hernan M.A., Willett W.C., and Ascherio A. Obesity and the risk of Parkinson's disease. Am J Epidemiol 159 (2004) 547-555
27. Logroscino G., Marder K., Cote L., Tang M.X., Shea S., and Mayeux R. Dietary lipids and antioxidants in Parkinson's disease: a population-based, case-control study. Ann Neurol 39 (1996) 89-94
28. Chen H., Zhang S.M., Schwarzschild M.A., Hernan M.A., and Ascherio A. Physical activity and the risk of Parkinson disease. Neurology 64 (2005) 664-669
29. Conover C.A., Lee P.D., Kanaley J.A., Clarkson J.T., and Jensen M.D. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. J Clin Endocrinol Metab 74 (1992) 1355-1360
30. Frystyk J., Grofte T., Skjaerbaek C., and Orskov H. The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults. J Clin Endocrinol Metab 82 (1997) 3124-3127
31. Baserga R., Peruzzi F., and Reiss K. The IGF-1 receptor in cancer biology. Int J Cancer 107 (2003) 873-877
32. Sandor R.S. Effects of fasting on growth and glycolysis of the Ehrlich ascites tumor. J Natl Cancer Inst 56 (1976) 427-428
33. Chan W., McElhanon S., Kaplan A.M., and Banks Jr. W.L. Effects of three feeding schedules on tumor and host of Lewis lung carcinoma-bearing mice. Proc Soc Exp Biol Med 176 (1984) 460-466
34. Siegel I., Liu T.L., Nepomuceno N., and Gleicher N. Effects of short-term dietary restriction on survival of mammary ascites tumor-bearing rats. Cancer Invest 6 (1988) 677-680
35. Rocha N.S., Barbisan L.F., de Oliveira M.L., and de Camargo J.L. Effects of fasting and intermittent fasting on rat hepatocarcinogenesis induced by diethylnitrosamine. Teratog Carcinog Mutagen 22 (2002) 129-138
36. Berrigan D., Perkins S.N., Haines D.C., and Hursting S.D. Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23 (2002) 817-822
37. Dunn S.E., Kari F.W., French J., Leininger J.R., Travlos G., Wilson R., et al. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57 (1997) 4667-4672
38. Kari F.W., Dunn S.E., French J.E., and Barrett J.C. Roles for insulin-like growth factor-1 in mediating the anti-carcinogenic effects of caloric restriction. J Nutr Health Aging 3 (1999) 92-101
39. Allen N.E., Appleby P.N., Davey G.K., Kaaks R., Rinaldi S., and Key T.J. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev 11 (2002) 1441-1448
40. McCarty M.F. Insulin and IGF-I as determinants of low "Western cancer rates in the rural third world. Int J Epidemiol 33 (2004) 908-910
41. Landsberg L. Insulin and the sympathetic nervous system in the pathophysiology of hypertension. Blood 1 (1996) 25-29 Press Suppl. JID - 9300787
42. Van De B.P., Hausberg M., Hoffman R.P., Mark A.L., and Anderson E.A. Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects. Am J Physiol 276 (1999) R178-R183
43. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 19 (2001) 523-528
44. Conradi E., and Jurk D. [Studies on the blood pressure behavior during clinical fasting treatment]. Z Gesamte Inn Med 24 (1969) 369-372
45. Gohler L., Hahnemann T., Michael N., Oehme P., Steglich H.D., Conradi E., et al. Reduction of plasma catecholamines in humans during clinically controlled severe underfeeding. Prev Med 30 (2000) 95-102
46. Goldhamer A., Lisle D., Parpia B., Anderson S.V., and Campbell T.C. Medically supervised water-only fasting in the treatment of hypertension. J Manipulative Physiol Ther 24 (2001) 335-339
47. Kushiro T., Kobayashi F., Osada H., Tomiyama H., Satoh K., Otsuka Y., et al. Role of sympathetic activity in blood pressure reduction with low calorie regimen. Hypertension 17 (1991) 965-968
48. Wan R., Camandola S., and Mattson M.P. Intermittent food deprivation improves cardiovascular and neuroendocrine responses to stress in rats. J Nutr 133 (2003) 1921-1929
49. Mattson M.P., and Wan R. Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. J Nutr Biochem 16 (2005) 129-137
50. Lissner L., Bengtsson C., Lapidus L., Kristjansson K., and Wedel H. Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 20 (1992) 797-801
51. Liese A.D., Mayer-Davis E.J., Chambless L.E., Folsom A.R., Sharrett A.R., Brancati F.L., et al. Elevated fasting insulin predicts incident hypertension: the ARIC study. Atherosclerosis Risk in Communities Study Investigators. J Hypertens 17 (1999) 1169-1177
52. Kashiwabara H., Inaba M., Maruno Y., Morita T., Awata T., Negishi K., et al. Insulin levels during fasting and the glucose tolerance test and Homa's index predict subsequent development of hypertension. J Hypertens 18 (2000) 83-88
53. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., and Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290 (2003) 486-494
54. Biaggioni I. Sympathetic control of the circulation in hypertension: lessons from autonomic disorders. Curr Opin Nephrol Hypertens 12 (2003) 175-180
55. Grassi G., Cattaneo B.M., Seravalle G., Lanfranchi A., and Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 31 (1998) 68-72
56. Facchini F.S., Stoohs R.A., and Reaven G.M. Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia, and heart rate. Am J Hypertens 9 (1996) 1013-1017
57. Sztajzel J. Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss Med Wkly 134 (2004) 514-522
58. Jurca R., Church T.S., Morss G.M., Jordan A.N., and Earnest C.P. Eight weeks of moderate-intensity exercise training increases heart rate variability in sedentary postmenopausal women. Am Heart J 147 (2004) e21
59. Sandercock G.R., Bromley P.D., and Brodie D.A. Effects of exercise on heart rate variability: inferences from meta-analysis. Med Sci Sports Exerc 37 (2005) 433-439